Background: Perioperative prophylactic antibiotic treatment significantly influences intestinal microflora, resulting in impaired bowel functioning in some patients, sometimes requiring further investigations. This may lead to a worse health-related quality of life (HRQoL). Probiotics administrated in the early post-operative period may help avoiding such nuisances in older people. Methods: We prospectively enrolled patients undergoing laparoscopic colorectal surgery aged over 70 years between 2005 and 2012. The study was approved by IRB. All patients received perioperative antibiotic treatment. Patients were randomized to one of two treatment arms: Group A patients received probiotics after surgery (VSL#3, VSL Pharmaceuticals, Inc. USA -900 × 10 9 daily, while Group B patients received a Placebo (cornstarch). Patients were further divided in sub-groups whether ileo-caecal valve was spared or not. Patients were followed-up every 7 days for 4 weeks. Patients daily annotated bowel frequency, stool shape and consistency -according to Bristol's scale. HRQoL was assessed every week by means of SF-36 questionnaire. Results: Group A included 10 while Group B included 8 patients. One patient in each group experienced a postoperative complication. Group A patients had fewer bowel movements than controls, during every week. Stool consistency was higher in patients undergoing resections including ileo-caecal valve receiving VSL#3. HRQoL gradually increased in both groups; Group A patients had higher "social functioning" item scores at week 1 and 4 than controls. Conclusions: Elderly patients undergoing resection of ileo-caecal valve may benefit from an early probiotics administration pathway after perioperative antibiotic treatment.
Background
Intestinal microflora is profoundly influenced by antibiotic therapy needed peri-operatively in patients undergoing large bowel resections. The effects of short antibiotic therapy on gut microbiota can last more than 24 months [1] . Elderly patients operated on may often suffer from functional intestinal nuisances in the postoperative period, which may require further investigations and treatments. The possibility of modulating intestinal microflora by means of probiotic formulations could potentially lead to a better functioning of gut mucosal barrier, resulting in reduced septic complications. Also, bowel control and health-related quality of life (HRQoL) may be improved.
Aim of our study was to investigate whether the administration of probiotics in the early postoperative * Correspondence: gipe1984@gmail.com 1 Unit of General and Geriatric Surgery, Second University of Naples, Italy Full list of author information is available at the end of the article period after large bowel resection can facilitate the restoration of bowel function and reduce symptoms in elderly patients.
Methods
This is a prospective double blind randomized trial on patients aged over 70 years undergoing laparoscopic colonic resection in our Unit between 2005 and January 2012. The study was approved by IRB and all patients were included after signing an informed consent. Patients were randomly assigned to Group A (antibiotic + probiotic) or Group B (antibiotic + placebo). In each group, patients were further divided in sub-groups 1 and 2 whether surgery preserved or not ileocaecal valve, respectively. After the discharge, patients were seen in outpatient settings by a resident every 7 days for 4 weeks. Neither patients nor residents knew which treatment (probiotic/placebo) was being administered.
Exclusion criteria

Dukes D colorectal cancer
Inflammatory bowel diseases Need for temporary or definitive oostomy Allergy to antibiotics/probiotics/placebo used in the study 
Probiotic/placebo therapy
Group A patients received probiotics (VSL#3, VSL Pharmaceuticals, Inc. USA) at the dose of 900 × 10 9 daily, divided in two administrations from one day after discontinuation of antibiotic through four weeks. The probiotic composition is the following: Streptococcus thermophilus
bulgaricus DSM 24734); maltose; silicium dioxide. Group B patients received the Placebo composed of cornstarch (base ingredient for probiotic product), indistinguishable from VSL#3, in a similar fashion.
Bowel function assessment
During probiotic/placebo treatment patients were requested to complete a daily report annotating: bowel movement/s, body temperature, stool shape and consistency. Stool characters were defined according to Bristol scale [2] , a 7-point scale in which stools were scored according to cohesion and surface cracking, as follows: 1, separate hard lumps (like nuts); 2, sausage-shaped, but lumpy; 3, like a sausage or snake, but with cracks on its surface; 4, like a sausage or snake, and smooth and soft; 5, soft blobs with a clear cut edge; 6, fluffy pieces with ragged edges and mushy; and 7, watery with no solid pieces).
Quality of life assessment
Patients completed the SF-36 questionnaire every week during probiotic/placebo treatment.
Statistical analysis
We enrolled all consecutive patients undergoing surgery in the study period fitting inclusion criteria. Data are presented as mean ± SD. Categorical variable were compared by means of Fisher's exact test; for continuous parameters Student's t test was used.
Results
Group A included 10 patients (5 male); Group B included 8 patients (4 male). Patients characteristics and surgical parameters are reported in Table 1 . One patient in each group experienced a postoperative complication, managed conservatively. Irrespective of ileo-caecal valve preservation, Group A patients had fewer bowel movements than controls, during every week (Figure 1 ).
No differences were observed concerning overall stool consistency; however it was higher in patients undergoing ileocolic resections including ileo-caecal valve receiving VSL#3 (Figure 2) .
No febrile episodes (body temperature ≥ 37.3°C) were recorded.
Both groups showed a gradual increase in HRQoL from first through fourth week; with respect to item "social Table 1 Characteristics of patients and surgical details functioning", group A patients showed significantly higher score at week 1 and 4 than patients receiving placebo ( Figure 3) . No adverse effects to VSL#3 or placebo were observed.
Discussion
Perioperative antibiotic therapy, although demandable, are responsible for relevant imbalances of intestinal microbiota [1, 3] . This may lead to higher risk of infectious complications due to bacterial translocation. Also, the imbalance in components of gut microflora is responsible for intensified symptoms perception [1] . It has been reported that probiotic formulations are not effective to reduce the rate of postoperative septic complications in patients undergoing elective abdominal surgery [3] . However, literature lacks studies investigating the effect of probiotics administration in the early post-operative period on symptoms perception in elderly patients undergoing large bowel resection.
In our series, we observed a lower frequency of evacuations in patients receiving probiotics, although not statistically significant; stool consistency was slightly higher in patients receiving resection not preserving ileo-caecal valve treated with probiotics. HRQoL was comparable in both groups, but patients in the probiotic group achieved a better social functioning than controls at 1-and 4-week follow-up.
Conclusions
Even if therapy with probiotics did not show a protective effect on postoperative complications, frail patients undergoing resection of ileo-caecal valve may benefit from an early probiotics administration pathway after perioperative antibiotic treatment. Bowel frequency may be lower, irrespective of the type of surgery. These observations support the usefulness of early probiotic administration in achieving a prompt restoration of function and return to everyday activities.
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